According to our report, the size of the European Bioinformatics Market was worth USD 2.91 billion in 2021 and estimated to be growing at a CAGR of 14.3%, to reach USD 5.69 billion by 2026.
Bioinformatics is a field of study in which biological data is interpreted through the development and use of new software tools and methods. It is an interdisciplinary field comprising of engineering, mathematics, statistics and computer science to analyze the biological information acquired—bioinformatics envelopes all the biological studies which are done by using computer programming as the tool. Bioinformatics is most often used for knowing candidate genes and single nucleotide polymorphisms.
Bioinformatics is used in quite a few areas of biology. It helps in obtaining useful information from the text and in gene ontology to organize and name data. In the field of genomics and genetics, it assists in sequencing genomes and noting their mutations. It is useful in understanding evolutionary aspects of molecular biology by comparing genetic and genomic data. In the field of experimental molecular biology, it proves very useful because of techniques such as image and signal processing. It also helps in analyzing gene and protein expression and regulation.
The driving factors of Europe Bioinformatics market are growing need for sequencing protein and nucleic acids, rising assistance of this field in manufacturing new medicines and clinical diagnostics, increasing initiatives from the government, rising demand for integrated bioinformatics systems in proteomics and genomics, an increasing number of partnerships between research organizations and companies among others.
The constraints of this market are high costs, lack of skilled workers, lack of user-friendly tools and lack of interoperability among various data formats.
This research report has been segmented & sub-segmented into the following categories:
Regionally, Europe is the second-largest market in the world. Factors such as the increased need for protein and nucleic acid sequencing, increasing funding for research and technological advancements are expected to propel the growth of this market in the region.
During the forecast period, the Germany bioinformatics market is expected to have the highest shares of the European Bioinformatics market, as well as the bioinformatics market in France and U.K., are expected to increase in the forecast period with highest CAGR. Increasing disposable income in the countries and the adoption of the new technologies from the users are likely to bolster the demand of the market. Also, the increasing use of advanced tools by the end-users is expected to boost the Bioinformatics growth in the forecast period.
List of the companies playing a dominating role in the Europe Bioinformatics Market profiled in this report are Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc. and Waters Corporation among others.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sector
5.1.1 Animal Biotechnology
5.1.2 Environmental Biotechnology
5.1.2.1 Alternative Energy Sources
5.1.2.2 Waste Clean-Up/Bioremediation
5.1.2.3 Climate Change Studies
5.1.3 Agricultural Biotechnology
5.1.3.1 Crop Yield Improvement
5.1.3.2 Pest Resistance
5.1.3.3 Improvement of Plant Resistance
5.1.3.4 Biodiversity Informatics
5.1.3.5 Nutritional Quality Improvement
5.1.4 Forensic Biotechnology
5.1.5 Medical Biotechnology
5.1.5.1 Drug Development
5.1.5.2 Clinical Diagnostics
5.1.5.3 Molecular Medicine
5.1.5.3.1 Personalized Medicine
5.1.5.3.2 Preventive Medicine
5.1.5.4 Gene Therapy
5.1.5.5 Reproductive Biotechnology
5.1.6 Academics
5.1.7 Other sectors
5.1.8 Y-o-Y Growth Analysis, By Sector
5.1.9 Market Attractiveness Analysis, By Sector
5.1.10 Market Share Analysis, By Sector
5.2 Products and Services
5.2.1 Bioinformatics Platforms
5.2.1.1 Sequence Analysis Platforms
5.2.1.2 Sequence Alignment Platforms
5.2.1.3 Sequence Manipulation Platforms
5.2.1.4 Structural and Functional Analysis Platforms
5.2.1.5 Other Bioinformatics Platforms
5.2.2 Knowledge Management Tools
5.2.2.1 Generalized Knowledge Management Tools
5.2.2.2 Specialized Knowledge Management Tools
5.2.3 Bioinformatics Services
5.2.3.1 Data Analysis
5.2.3.2 Sequencing Services
5.2.3.3 Other Bioinformatics Services
5.2.3.4 Database and Management Services
5.2.4 Y-o-Y Growth Analysis, By Products and Services
5.2.5 Market Attractiveness Analysis, By Products and Services
5.2.6 Market Share Analysis, By Products and Services
5.3 Application
5.3.1 Proteomics
5.3.2 Transcriptomics
5.3.3 Molecular Phylogenetics
5.3.4 Chemoinformatics
5.3.5 Drug Design and Genomics
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Sector
6.1.3.2 By Products and Services
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Sector
6.1.4.2 By Products and Services
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Sector
6.1.5.2 By Products and Services
6.1.5.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Affymetrix Inc.
8.3 Applied Biological Materials (ABM)
8.4 3rd Millenium Inc.
8.5 Illumina Inc.,
8.6 Thermo Fisher Scientific Inc.
8.7 Qiagen N.V.
8.8 Biomax Informatics Ag
8.9 DNAnexus, Inc.
8.10 Waters Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
